Literature DB >> 25618128

The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure.

Stanislava Kalafutova1, Bozena Juraskova2, Jiri Vlcek1.   

Abstract

Nowadays NSAIDs are the most frequently used groups of drugs, especially because of their availability. Their consumption is high among older people, who are much more sensitive to the side effects, and who are often also taking other drugs which can interact with them. Moreover, the majority of the older population is suffering from hypertension. This could well explain the commonly encountered experience of drug interaction between NSAIDs and antihypertensive drugs, which is very common in clinical practice. The severity of this drug interaction is classified as class C, with a recommendation to monitor therapy. However, even a minor long-term increase in blood pressure can significantly increase the risk of cardiovascular mortality, while mortality rates can possibly be reduced by sufficiently effective treatment of hypertension. Therefore, in clinical practice, this type of interaction should not be overlooked as a major cause of failure of hypertension treatment in older patients, as well in many cases in general. The present article focusses on the mechanism and the degree of influence on the blood pressure of particular types of antihypertensive agents used in combination with NSAID. Not all groups of antihypertensive drugs are affected to the same degree; some are more affected, and others, such as calcium channel blockers, are not affected at all. Similarly, not every NSAID increases blood pressure. Many studies, some of which are analyzed in this article, present evidence of the degree of the influence NSAIDs have on blood pressure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25618128     DOI: 10.17219/acem/37357

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  8 in total

Review 1.  Anesthetic Management of the Hypertensive Patient: Part II.

Authors:  Russell Yancey
Journal:  Anesth Prog       Date:  2018

Review 2.  [Choosing wisely recommendations in nephrology].

Authors:  J Galle; J Floege
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

3.  Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care.

Authors:  Christopher J D Threapleton; James E Kimpton; Iain M Carey; Stephen DeWilde; Derek G Cook; Tess Harris; Emma H Baker
Journal:  Br J Clin Pharmacol       Date:  2020-03-16       Impact factor: 4.335

Review 4.  Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications.

Authors:  Andrea Fanelli; Daniela Ghisi; Pierangelo Lora Aprile; Francesco Lapi
Journal:  Ther Adv Drug Saf       Date:  2017-02-10

Review 5.  Pharmacological Treatment in the Management of Glenohumeral Osteoarthritis.

Authors:  Omar A Al-Mohrej; Carlos Prada; Timothy Leroux; Harsha Shanthanna; Moin Khan
Journal:  Drugs Aging       Date:  2022-01-19       Impact factor: 3.923

6.  EVALUATION OF THE ANTI-INFLAMMATORY CAPACITY OF BETA-SITOSTEROL IN RODENT ASSAYS.

Authors:  Rogelio Paniagua-Pérez; Gabriela Flores-Mondragón; Celia Reyes-Legorreta; Brígida Herrera-López; Isabel Cervantes-Hernández; Osiris Madrigal-Santillán; José Antonio Morales-González; Isela Álvarez-González; Eduardo Madrigal-Bujaidar
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

7.  Prescription Pattern Analysis of Nonsteroidal Anti-inflammatory Drugs in the Northeastern Iranian Population.

Authors:  Majid Zeinali; Jamshid Tabeshpour; Seyed Vahid Maziar; Zhila Taherzadeh; Mohammad Reza Zirak; Danielle Sent; Kamal Razavi Azarkhiavi; Saeid Eslami
Journal:  J Res Pharm Pract       Date:  2017 Oct-Dec

8.  Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.

Authors:  Zbigniew Heleniak; Magdalena Cieplińska; Tomasz Szychliński; Dymitr Rychter; Kalina Jagodzińska; Alicja Kłos; Izabela Kuźmiuk; Marzena Jakimowicz Tylicka; Leszek Tylicki; Bolesław Rutkowski; Alicja Dębska-Ślizień
Journal:  J Nephrol       Date:  2016-09-27       Impact factor: 3.902

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.